Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARDT NASDAQ:CELC NASDAQ:INNV NASDAQ:LFST On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health$12.48-0.1%$12.46$10.10▼$20.72$1.79BN/A485,955 shs447,648 shsCELCCelcuity$51.79-0.2%$22.44$7.57▼$53.86$2.02B0.682.84 million shs908,850 shsINNVInnovAge$3.43-2.8%$3.82$2.60▼$6.69$476.60M0.5127,770 shs17,449 shsLFSTLifeStance Health Group$5.44-2.5%$4.69$3.74▼$8.61$2.17B1.133.18 million shs3.24 million shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health-0.04%+5.14%+3.91%-18.98%-22.19%CELCCelcuity-0.19%+12.88%+273.67%+388.12%+217.15%INNVInnovAge-2.83%+3.63%-21.51%-18.14%-41.77%LFSTLifeStance Health Group-2.51%+24.49%+23.64%-6.85%-4.23%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARDTArdent Health3.2622 of 5 stars3.40.00.00.02.40.03.1CELCCelcuity0.9806 of 5 stars1.52.00.00.02.23.30.0INNVInnovAge2.6131 of 5 stars2.84.00.00.03.11.70.6LFSTLifeStance Health Group3.2539 of 5 stars3.44.00.00.02.72.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDTArdent Health 2.70Moderate Buy$19.5656.73% UpsideCELCCelcuity 3.00Buy$47.40-8.48% DownsideINNVInnovAge 1.50Reduce$5.0045.77% UpsideLFSTLifeStance Health Group 2.86Moderate Buy$8.5056.25% UpsideCurrent Analyst Ratings BreakdownLatest INNV, CELC, ARDT, and LFST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/15/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$74.00 ➝ $70.008/11/2025ARDTArdent HealthJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$18.00 ➝ $15.008/8/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.50 ➝ $9.008/7/2025ARDTArdent HealthKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$24.00 ➝ $20.007/28/2025CELCCelcuityLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$28.00 ➝ $60.007/28/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$27.00 ➝ $50.007/28/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.007/25/2025LFSTLifeStance Health GroupBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$8.007/16/2025ARDTArdent HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeNeutral ➝ Underperform$15.50 ➝ $14.607/1/2025CELCCelcuityStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$30.006/30/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.00(Data available from 8/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDTArdent Health$6.20B0.29$2.54 per share4.92$11.52 per share1.08CELCCelcuityN/AN/AN/AN/A$3.11 per shareN/AINNVInnovAge$763.85M0.61N/AN/A$2.04 per share1.68LFSTLifeStance Health Group$1.25B1.69$0.04 per share140.72$3.79 per share1.44Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDTArdent Health$210.34M$1.816.906.375.524.11%16.66%5.18%N/ACELCCelcuity-$111.78M-$3.45N/AN/AN/AN/A-126.74%-60.59%N/AINNVInnovAge-$21.34M-$0.23N/A57.17N/A-3.75%-11.91%-5.85%9/9/2025 (Estimated)LFSTLifeStance Health Group-$57.44M-$0.05N/AN/AN/A-1.23%-1.11%-0.76%N/ALatest INNV, CELC, ARDT, and LFST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/9/2025Q4 2025INNVInnovAge-$0.02N/AN/AN/A$219.80 millionN/A8/14/2025Q2 2025CELCCelcuity-$0.90-$1.04-$0.14-$1.04N/AN/A8/7/2025Q2 2025LFSTLifeStance Health Group-$0.03-$0.01+$0.02-$0.01$345.05 million$345.31 million8/5/2025Q2 2025ARDTArdent Health$0.30$0.52+$0.22$0.52$1.54 billion$1.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARDTArdent HealthN/AN/AN/AN/AN/ACELCCelcuityN/AN/AN/AN/AN/AINNVInnovAgeN/AN/AN/AN/AN/ALFSTLifeStance Health GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDTArdent Health0.662.132.00CELCCelcuity1.146.616.61INNVInnovAge0.040.780.78LFSTLifeStance Health Group0.191.481.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDTArdent HealthN/ACELCCelcuity63.33%INNVInnovAge12.26%LFSTLifeStance Health Group85.50%Insider OwnershipCompanyInsider OwnershipARDTArdent Health1.70%CELCCelcuity15.77%INNVInnovAge1.40%LFSTLifeStance Health Group3.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDTArdent Health24,900143.11 million140.67 millionOptionableCELCCelcuity4038.91 million32.78 millionOptionableINNVInnovAge2,350135.01 million133.12 millionOptionableLFSTLifeStance Health Group10,218388.94 million376.49 millionOptionableINNV, CELC, ARDT, and LFST HeadlinesRecent News About These CompaniesLifeStance Health Group (NASDAQ:LFST) Trading 4.5% Higher - Here's Why3 hours ago | marketbeat.comLifeStance Health Group (NASDAQ:LFST) Shares Gap Up - Should You Buy?August 15 at 2:07 PM | marketbeat.comLifeStance (LFST) Extends 4-Day Run on Strong EarningsAugust 14 at 10:10 PM | finance.yahoo.comLifeStance Health’s Earnings Call Highlights Robust GrowthAugust 13 at 2:09 AM | msn.comLifeStance Health Group (NASDAQ:LFST) Stock Rating Upgraded by Wall Street ZenAugust 11, 2025 | americanbankingnews.comUBS Group Forecasts Strong Price Appreciation for LifeStance Health Group (NASDAQ:LFST) StockAugust 11, 2025 | americanbankingnews.comResearch Analysts Set Expectations for LFST Q1 EarningsAugust 10, 2025 | americanbankingnews.comLifeStance Health Group (NASDAQ:LFST) Raised to Buy at Wall Street ZenAugust 10, 2025 | marketbeat.comLifeStance Health Group (NASDAQ:LFST) Shares Up 9.4% on Better-Than-Expected EarningsAugust 10, 2025 | americanbankingnews.comUBS Group Raises LifeStance Health Group (NASDAQ:LFST) Price Target to $9.00August 9, 2025 | marketbeat.comLifeStance Health Group (NASDAQ:LFST) Trading Up 9.4% on Earnings BeatAugust 9, 2025 | marketbeat.comWhat is William Blair's Estimate for LFST Q1 Earnings?August 9, 2025 | marketbeat.comWhy LifeStance Health Group (LFST) Stock Is Up TodayAugust 9, 2025 | msn.comLifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.42 Average PT from AnalystsAugust 9, 2025 | americanbankingnews.comLifeStance Health Group, Inc. (LFST) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comLifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue EstimatesAugust 7, 2025 | zacks.comLifeStance Reports Second Quarter 2025 ResultsAugust 7, 2025 | globenewswire.comLifeStance Health Group (LFST) Reports Earnings Tomorrow: What To ExpectAugust 6, 2025 | msn.comLifeStance Health Group, Inc. (NASDAQ:LFST) Given Consensus Rating of "Moderate Buy" by AnalystsAugust 6, 2025 | marketbeat.comMackenzie Financial Corp Invests $1.34 Million in LifeStance Health Group, Inc. (NASDAQ:LFST)August 5, 2025 | marketbeat.com214,932 Shares in LifeStance Health Group, Inc. (NASDAQ:LFST) Acquired by Universal Beteiligungs und Servicegesellschaft mbHAugust 2, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINNV, CELC, ARDT, and LFST Company DescriptionsArdent Health NYSE:ARDT$12.48 -0.01 (-0.08%) Closing price 08/15/2025 03:58 PM EasternExtended Trading$12.49 +0.01 (+0.08%) As of 08/15/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Celcuity NASDAQ:CELC$51.79 -0.10 (-0.19%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$51.26 -0.53 (-1.02%) As of 08/15/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.InnovAge NASDAQ:INNV$3.43 -0.10 (-2.83%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$3.44 +0.00 (+0.15%) As of 08/15/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.LifeStance Health Group NASDAQ:LFST$5.44 -0.14 (-2.51%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$5.45 +0.01 (+0.18%) As of 08/15/2025 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Applied Materials' Knee-Jerk Sell-Off Is Your Signal to Buy Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH Deere’s Sell-Off Could Be a Long-Term Buying Chance 3 Restaurant Stocks That Will Outperform in Q3 and Q4 Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore The Real Reason Ford Stock Is Rallying—Can It Keep Going? Arista Networks: Cashing In as the Tollbooth for AI Traffic Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.